marijuana stocks

Form 8-K for VAPOR CORP.


25-Jan-2016

Other Events, Financial Statements and Exhibits

Item 8.01 Other Events.On January 22, 2016, Vapor Corp. (“Vapor” or the “Company”) issued a press release announcing that the Units in the July 2015 offering will be separating on January 23, 2016 (with an effective date of January 25, 2016) (the “Separation Date”). On the Separation Date, each Unit will automatically separate into one-fourth of a share of Series A Convertible Preferred Stock and Series A Warrants. Each one-fourth share of Series A Convertible Preferred Stock may be converted into 10 shares of Vapor common stock by the holder by providing written notice to Vapor and its transfer agent by using the Convertible Preferred Stock Conversion Form filed asExhibit 99.1 to this Form 8-K. Holders of Warrants may exercise the Warrants by contacting their broker and sending written notice to the Company. Please use the Warrant Exercise Notification Form filed as Exhibit 99.2 to this Form 8-K (in lieu of the exercise notice attached to the Warrant). All notifications and questions regarding the conversion of the Preferred Stock and exercise of the Warrants should be emailed to excashless@vpco.com.

 

Item 9.01 Financial Statements and Exhibits.99.1 Convertible Preferred Stock Conversion Form

99.2 Warrant Exercise Notification Form

99.3 Press Release dated January 22, 2016

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tilray Brands, Inc. (TLRY) Manitoba Harvest Hemp Foods Introduces Protein-Rich Breakfast

Manitoba Harvest Hemp Foods Introduces Protein-Rich Breakfast Staples With New Superseed Instant…

GT Biopharma (OXISD) Hires Former Pfizer CMO/Vice President and Senior Director of Oncology Research as CMO

LOS ANGELES, CA / ACCESSWIRE / September 7, 2017 / GT Biopharma…

Tetra Bio-Pharma Inc. (TBPMF) FDA Provides Positive Feedback on Pre-Investigational New Drug Application for ARDS-003

FDA Provides Positive Feedback on Tetra Bio-Pharma’s Pre-Investigational New Drug Application for…

Future Farm Technologies Inc. (FFRMF) Provides Update on Operations and Growth Initiatives

Future Farm Provides Update on Operations and Growth Initiatives Future Farm Technologies…